Optimising Resource Allocation Via Prediction of Outcomes for Covid-19
Launched by NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST · Jul 15, 2020
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
Background.
Relatively simple clinical risk scores based upon easily available clinical information can greatly aid in the triaging of patients to early discharge or more rapid and intensive intervention. One example of this is in upper gastrointestinal bleeding where several such scores (https://www.mdcalc.com/glasgow-blatchford-bleeding-score-gbs4 5; https://www.mdcalc.com/rockall-score-upper-gi-bleeding-complete6) have permitted safe early discharge thereby relieving pressure on hospitals. The investigators believe that similar results might potentially be achievable from data routinely...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • All patients admitted to Nottingham University Hospitals Trust either suspected of having Covid-19 infection or in whom the diagnosis is eventually confirmed and who are over the age of 18 years
- Exclusion Criteria:
- • • Aged under 18.
About Nottingham University Hospitals Nhs Trust
Nottingham University Hospitals NHS Trust is a leading healthcare provider in the UK, dedicated to delivering high-quality patient care and advancing medical research. Comprising two major hospitals, Queen's Medical Centre and Nottingham City Hospital, the Trust is at the forefront of clinical innovation and education. With a strong emphasis on translational research, Nottingham University Hospitals NHS Trust actively sponsors clinical trials aimed at improving treatment outcomes and understanding various health conditions. The Trust collaborates with academic institutions, healthcare professionals, and industry partners to foster a robust research environment that enhances clinical practice and contributes to evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nottingham, , United Kingdom
Nottingham, , United Kingdom
Patients applied
Trial Officials
Timothy R Card, FRCP, PhD
Principal Investigator
University of Nottingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials